For patients and relatives

The project aims to investigate whether the newly developed ultrasound probe "RescueDoppler" can measure blood flow in the carotid artery during ongoing cardiopulmonary resuscitation (CPR) for patients experiencing cardiac arrest. 

 

This is the first time RescueDoppler is being tested on patients. The ultrasound probe system has received approval from the Norwegian Medicines Agency for clinical testing on cardiac arrest patients.

​

The primary goal of the study is to investigate whether continuous monitoring of blood flow in the carotid artery using RescueDoppler is a sensitive method for measuring pulse. This could provide better diagnostic information and decision support regarding further treatment. The study is planned to last a little over a year.

 

Cimon Medical AS is the company that developed RescueDoppler, and NTNU is responsible for the management of the research project.

​

Considering the acute and life-threatening situation for the patient, it is impossible to obtain an informed consent at time for enrolment in the clinical investigation. We therefore seek approval retrospectively.